Mixed results over at $APHA in Q1. Special thanks to @vanmalas, @cannabisatwork’s @AlisonLMcMahon, and my BOY @ScottW_Grizzle (can someone send him this? I’m blocked.)
The market has the hiccups, but it’s steady as she goes at $OGI. Featuring cameos by @pancakenap420 and @chernandburn Organigram Earnings give a scrambled market something to believe in
An adequate volume of quality bud continues to elude the legal marijuana sector. Are these facilities being staffed right?
Cannabisphere all a-twitter as @chris_pelle jumps ship for $WEED. Will she still use @grizzlemedia as a source? plus: parts of that @gmpsecurities $CGC downgrade look familiar…
We’ve read the $CGC / $WEED Q4 quarterlies, and are here to bring you the greatest hits, including some curious reporting changes.
$OGI had a banger of a quarter and is still one of our favorite Canadian cultivators in the latest marijuana datajam.
$EMC & $ALEF stand to come out ahead on $TLRY’s Natura deal. But can they keep their supply?
Breaking down the fundamentals behind the hype in the $GGB offer for $APHA.
$TLRY’s deal for Natura Naturals is putting on a clinic in risk pricing, just in time for our series on de-risking in the cannabis space.
All eyes were on $APHA Friday, as the best soap opera in the pot world arrived at the much-anticipated culmination of its latest high-drama plot arc, and payed it off in epic fashion.